Literature DB >> 10695836

Soft neurological signs in schizophrenic patients and their nonpsychotic siblings.

Y L Chen1, Y H Chen, F L Mak.   

Abstract

This study examined neurological signs as familial vulnerability factors to schizophrenia. Fifteen Chinese schizophrenic patients, 21 of their nonpsychotic siblings, and 26 healthy volunteers, matched for age, sex, and education, were assessed by using the Cambridge Neurological Inventory. Results showed that patients and their siblings had significantly higher global neurological impairment than controls. The severity of motor coordination impairment of the siblings was in between patients and controls. This may suggest either patients have higher genetic vulnerability for the neurological abnormality and schizophrenia than their nonpsychotic siblings or the disease can further worsen the preexisting neurological deficit. Disinhibition signs were similar in patients and siblings, but significantly less in controls indicating its familial nature. Extrapyramidal and sensory integration signs were similar in siblings and controls, but significantly more severe in patients, suggesting nonfamilial abnormalities. In conclusion, these findings may imply different etiological origins for different subgroups of neurological signs.

Entities:  

Mesh:

Year:  2000        PMID: 10695836     DOI: 10.1097/00005053-200002000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  14 in total

Review 1.  Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.

Authors:  Fumiko Maeda; Alvaro Pascual-Leone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-26       Impact factor: 4.530

Review 2.  [Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

Authors:  T Wobrock; D Kadovic; P Falkai
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

Review 3.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

4.  Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia.

Authors:  Ute Gschwandtner; Marlon Pflüger; Jacqueline Aston; Stefan Borgwardt; Margret Drewe; Rolf-Dieter Stieglitz; Anita Riecher-Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-14       Impact factor: 5.270

5.  Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.

Authors:  Jeroen P F Koning; Diederik E Tenback; Jim van Os; André Aleman; René S Kahn; Peter N van Harten
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

Review 6.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

7.  Neurological soft signs in schizophrenia: a meta-analysis.

Authors:  Raymond C K Chan; Ting Xu; R Walter Heinrichs; Yue Yu; Ya Wang
Journal:  Schizophr Bull       Date:  2009-04-17       Impact factor: 9.306

8.  Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations.

Authors:  Anwar Mechri; Marie-Chantal Bourdel; Héla Slama; David Gourion; Lotfi Gaha; Marie-Odile Krebs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-17       Impact factor: 5.270

9.  Sensory and motor secondary symptoms as indicators of brain vulnerability.

Authors:  Nava Levit-Binnun; Michael Davidovitch; Yulia Golland
Journal:  J Neurodev Disord       Date:  2013-09-24       Impact factor: 4.025

10.  Neurological soft signs in individuals with pathological gambling.

Authors:  Igor Elman; Tamara V Gurvits; Evelyne Tschibelu; Justin D Spring; Natasha B Lasko; Roger K Pitman
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.